M. Liu et al., IL-6 INDUCES TARGET-CELL RESISTANCE TO HIV-SPECIFIC CYTOTOXIC LYSIS, Journal of acquired immune deficiency syndromes and human retrovirology, 9(4), 1995, pp. 321-331
Interleukin-6 (IL-6) is a pleiotropic cytokine with multiple immunomod
ulatory functions. Although IL-6 enhances cytotoxic effector cell func
tion in vitro, we report the paradoxical effect of IL-6-induced resist
ance of target cells to lysis by cytotoxic T lymphocytes (CTL). The CT
L system employed autologous, Epstein-Barr virus-transformed B lymphob
lastoid target cells infected with vaccinia virus vectors carrying the
envelope gene from the human immunodeficiency virus (HIV). Effector c
ells were fresh peripheral blood mononuclear cells from HIV+ individua
ls. Resistance was induced by exposing B cell line targets to exogenou
s IL-6, or via an autocrine pathway in which IL-6 was secreted by the
target cells themselves. The IL-6 effect was dose dependent and revers
ible by antibody to IL-6. A large proportion of B cell lines from HIV individuals produced IL-6, and the lysis of HIV envelope-expressing B
cell targets was inversely proportional to the amounts of IL-6 produc
ed by the cell lines. These findings have significance for the utility
and interpretation of CTL assays as in vitro correlates of T cell com
petence and may be significant in vivo in situations such as HIV infec
tion where IL-6 production is increased.